72X Stock Overview
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
MicroPort CardioFlow Medtech Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.09 |
| 52 Week High | HK$0.23 |
| 52 Week Low | HK$0.029 |
| Beta | 0.37 |
| 11 Month Change | 150.00% |
| 3 Month Change | 53.85% |
| 1 Year Change | -45.12% |
| 33 Year Change | -87.41% |
| 5 Year Change | n/a |
| Change since IPO | -95.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| 72X | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 38.5% | 12.7% | 4.5% |
| 1Y | -45.1% | 9.1% | 13.4% |
Return vs Industry: 72X underperformed the German Medical Equipment industry which returned 9.1% over the past year.
Return vs Market: 72X underperformed the German Market which returned 13.4% over the past year.
Price Volatility
| 72X volatility | |
|---|---|
| 72X Average Weekly Movement | 97.7% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 72X's share price has been volatile over the past 3 months.
Volatility Over Time: 72X's weekly volatility has increased from 58% to 98% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 483 | Jeffrey R Lindstrom | www.cardioflowmedtech.com |
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, Angelguide tip-preshaped super sti¬ff guidewire, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company also provides technical consultation and technical services for medical devices clinical trial.
MicroPort CardioFlow Medtech Corporation Fundamentals Summary
| 72X fundamental statistics | |
|---|---|
| Market cap | €230.77m |
| Earnings (TTM) | -€44.53m |
| Revenue (TTM) | €48.91m |
4.7x
P/S Ratio-5.2x
P/E RatioIs 72X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 72X income statement (TTM) | |
|---|---|
| Revenue | CN¥382.91m |
| Cost of Revenue | CN¥111.38m |
| Gross Profit | CN¥271.53m |
| Other Expenses | CN¥620.13m |
| Earnings | -CN¥348.59m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 70.91% |
| Net Profit Margin | -91.04% |
| Debt/Equity Ratio | 1.2% |
How did 72X perform over the long term?
See historical performance and comparison